Mycobacterium avium and Mycobacterium intracellulare Infections in Patients with and without AIDS

A genetic probe (Gen-Probe) was used to evaluate potential epidemiologic and susceptibility differences of Mycobacterium avium complex (MAC) strains isolated from 154 patients with and without the acquired immunodeficiency syndrome (AIDS). Genetic analysis revealed that 98% of the 45 patients with A...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 160; no. 6; pp. 1037 - 1041
Main Authors Guthertz, Linda S., Damsker, Beca, Bottone, Edward J., Ford, Eleanor G., Midura, Thaddeus F., Janda, J. Michael
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.12.1989
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A genetic probe (Gen-Probe) was used to evaluate potential epidemiologic and susceptibility differences of Mycobacterium avium complex (MAC) strains isolated from 154 patients with and without the acquired immunodeficiency syndrome (AIDS). Genetic analysis revealed that 98% of the 45 patients with AIDS harbored only M. avium regardless of the anatomic or geographic source of the isolate; in contrast, ∼40% of MAC isolates recovered from 109 patients without AIDS were M. intracellulare. Most M. intracellulare of respiratory origin recovered from patients without AIDS were involved in infectious processes. When 95 MAC isolates (M. avium, n = 53; M. intracellulare, n = 42) were evaluated for in vitro susceptibility to primary or secondary antimycobacterial drugs, significant differences were noted. M. intracellulare was more susceptible to streptomycin, rifampin, and ethambutol than M. avium; the converse was true for ethionamide. The results of this study suggest potentially important differences in disease spectrum and in vitro susceptibility profile for M. avium and M. intracellulare.
Bibliography:Please address requests for reprints to Dr. J. Michael Janda, Microbial Diseases Laboratory, California Department of Health Services, 2151 Berkeley Way, Berkeley, CA 94704.
istex:363FB64F0ABDBDD76FA53F3C8D42AB3150399B98
ark:/67375/HXZ-QP7HXTVK-1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/160.6.1037